Asia
GlobalData issued a statement that the COVID-19 pandemic threatens biopharma in-house manufacturing.
Pharma and life sciences companies from across the globe provide updates on their pipelines and business practices.
BioSpace takes a quick look at some recent, key industry news that is not related to the coronavirus.
A summary of daily biopharma industry news. Please check out stories that are trending on March 25, 2020.
Four separate research groups in the U.S., Australia and China analyzed how temperature and humidity affect the coronavirus and they predict that hot summer months could decrease the presence of the virus in the Northern Hemisphere.
A summary of daily biopharma industry news. Please check out stories that are trending on March 24, 2020.
Under terms of the agreement, Astellas will make an upfront cash payment of $80 million to CytomX.
A University of Florida chemistry professor who fled the United States after falling under investigation for his ties to academic institutions in China has been at the forefront of developing a diagnostic test for the novel coronavirus in China.
The company did not know of her intention to leave the U.S. for China. They did not know she had been gone until the Chinese media reported the story. She was terminated by Biogen this week.
The company has nine drug candidates in human clinical trials.
PRESS RELEASES